Dosentrx
PrivateLast Round
Seed Round
Feb 18, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Dosentrx operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Grant round in February 2020.
Dosentrx is a healthtech company that developed ReX, a therapy management platform and smart pill-dispensing device intended to improve medication adherence for specialty treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Health IoT, Vertical SaaS, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dosentrx Comparables
Compare Dosentrx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spencer Health Solutions | 84% | |
| Vaica Medical | 81% | |
| Optimize Health | 77% |
For institutional investors. Book with your work email.
Dosentrx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Feb 18, 2026 | ||||
| Grant | Feb 10, 2020 | ||||
| Accelerator | Jun 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dosentrx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel National Digital Agency | Grant |
| Israel Innovation Authority | Grant |
| Startup Warrior | Seed |
| Ocho Capital | Seed |
| Texas Medical Center | Accelerator |
| Engage Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
$1.78M seed round completed.
For institutional investors. Book with your work email.
Dosentrx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dosentrx's valuation, stock price, and market status.
Is Dosentrx a public or private company?
Dosentrx is a private company.
What is the current stock price of Dosentrx?
Dosentrx is a private company, so its shares have no public market price. Caplight tracks Dosentrx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dosentrx worth (valuation)?
Valuation information for Dosentrx is not publicly available.
Can I buy Dosentrx stock?
Dosentrx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dosentrx's last funding round?
Dosentrx's most recent funding round was Seed Round on February 18, 2026.
Who are the main investors in Dosentrx?
Key investors in Dosentrx include Israel National Digital Agency, Israel Innovation Authority, Startup Warrior, Ocho Capital, Texas Medical Center.
Will Dosentrx IPO soon?
No public IPO plans have been announced for Dosentrx.
How can I track Dosentrx secondary market activity?
Caplight tracks bids, offers, and trades in Dosentrx's shares on secondary markets.